tiprankstipranks
Trending News
More News >
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
Advertisement

Palvella Therapeutics (PVLA) Technical Analysis

Compare
641 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
0Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
0Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Palvella Therapeutics’s (PVLA) Moving Averages Convergence Divergence (MACD) indicator is 4.01, suggesting Palvella Therapeutics is a Sell.
Palvella Therapeutics’s (PVLA) 20-Day exponential moving average is 38.32, while Palvella Therapeutics’s (PVLA) share price is $46.1, making it a Buy.
Palvella Therapeutics’s (PVLA) 50-Day exponential moving average is 32.60, while Palvella Therapeutics’s (PVLA) share price is $46.1, making it a Buy.

Palvella Therapeutics (PVLA) Pivot Points

Aug 15, 2025, 03:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
39.44
41.17
42.90
44.63
46.36
48.09
49.82
Fibonacci
41.17
42.49
43.30
44.63
45.95
46.76
48.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Palvella Therapeutics (PVLA) Moving Averages

Aug 15, 2025, 03:34 PM
Period
Simple
Exponential
MA5
43.31Buy
43.54Buy
MA10
40.59Buy
41.47Buy
MA20
38.55Buy
38.32Buy
MA50
30.12Buy
32.60Buy
MA100
27.08Buy
28.37Buy
MA200
22.03Buy
23.59Buy
Palvella Therapeutics’s (PVLA) 10-Day exponential moving average is 41.47, while Palvella Therapeutics’s (PVLA) share price is $46.1, making it a Buy.
Palvella Therapeutics’s (PVLA) 100-Day exponential moving average is 28.37, while Palvella Therapeutics’s (PVLA) share price is $46.1, making it a Buy.
Palvella Therapeutics’s (PVLA) stock price is $46.1 and Palvella Therapeutics’s (PVLA) 50-day simple moving average is 30.12, creating a Buy signal.
Palvella Therapeutics’s (PVLA) stock price is $46.1 and Palvella Therapeutics’s (PVLA) 100-day simple moving average is 27.08, creating a Buy signal.
Palvella Therapeutics’s (PVLA) stock price is $46.1 and Palvella Therapeutics’s (PVLA) 200-day simple moving average is 22.03, creating a Buy signal.

Palvella Therapeutics (PVLA) Technical Indicators

Aug 15, 2025, 03:34 PM
Name
Value
Implied Action
RSI (14)
83.04
Sell
STOCH (9,6)
88.19
Sell
STOCHRSI (14)
88.63
Sell
MACD (12,26)
4.01
Sell
ADX (14)
52.62
Sell
Williams %R
-10.83
Sell
CCI (14)
177.01
Sell
ATR (14)
2.40
-
Ultimate Oscillator
73.59
Buy
ROC
19.37
Buy
Palvella Therapeutics’s (PVLA) Relative Strength Index (RSI) is 83.04, creating a Sell signal.
Palvella Therapeutics’s (PVLA) Trend Strength Indicator (ADX) is 52.62, creating a Sell signal.
Palvella Therapeutics’s (PVLA) Commodity Channel Index (CCI) is 177.01, creating a Sell signal.
Palvella Therapeutics’s (PVLA) Price Rate of Change (ROC) is 19.37, creating a Buy signal.

FAQ

Is PVLA a Buy, Hold, or Sell?
Based on PVLA’s technical indicators, PVLA is a Buy.
    What is PVLA’s RSI (14)?
    PVLA’s RSI (14) is 83.04, which suggests PVLA is a Sell.
      What is PVLA’s MACD?
      PVLA’s MACD is 4.01, which suggests PVLA is a Sell.
        What is PVLA’s 5-day moving average?
        PVLA’s 5-day moving average is 43.31, which suggests PVLA is a Buy.
          What is PVLA’s 20-day moving average?
          PVLA 20-day moving average is 38.55, which suggests PVLA is a Buy.
            What is PVLA’s 50-day moving average?
            PVLA’s 50-day moving average is 30.12, which suggests PVLA is a Buy.
              What is PVLA’s 200-day moving average?
              PVLA’s 200-day moving average is 22.03, which suggests PVLA is a Buy.
                What is PVLA’s Williams % R (14)?
                PVLA’s Williams % R (14) is -10.83, which suggests PVLA is a Sell.
                  What is PVLA’s CCI (14)?
                  PVLA’s CCI (14) is 177.01, which suggests PVLA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis